+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 65Years
All Genders
ID06861010

Assessing Safety and Effectiveness of Ondansetron to Prevent Pancreatitis After Endoscopic Retrograde Cholangiopancreatography ERCP in Adults

Led by Tanta University · Updated on 2026-03-13

44

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of ondansetron in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis PEP, a common and serious complication after ERCP. This randomized, double-blind Phase 3 study focuses on adults aged 18 to 65 who require ERCP for suspected pancreato-biliary diseases. The study is sponsored by Tanta University and aims to reduce morbidity and mortality associated with PEP by investigating patient and procedure-related factors influencing its occurrence. Participants will be randomly assigned to receive either ondansetron or a placebo tablet two hours before undergoing ERCP. The placebo tablets look identical to the ondansetron tablets to maintain blinding. This setup allows the study to compare the effects of ondansetron against no active medication in preventing pancreatitis after the procedure. During the study, researchers will carefully monitor participants for the development of pancreatitis within 24 hours after ERCP, using established consensus criteria. Participants blood amylase and lipase levels will be checked before the procedure to ensure normal levels. The study involves close observation of safety and treatment outcomes, with the overall participation lasting through the procedure and the immediate 24-hour follow-up period for primary outcome assessment.

CONDITIONS

Brief Title

Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here